All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Visual abstract: Roxadustat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome: Open-label, Dose-selection, Lead-in Stage of a Phase 3 Study

Dec 13, 2021
Share:

Visual abstract


Visual abstract

To download this visual abstract, click below.

Download here

  1. Henry HD, et al. Am J Hematol. 2021. Online ahead of print. DOI: 10.1002/ajh.26397 

Share: